Center Book Partners LP Merus N.V. Transaction History
Center Book Partners LP
- $1.54 Billion
- Q4 2024
A detailed history of Center Book Partners LP transactions in Merus N.V. stock. As of the latest transaction made, Center Book Partners LP holds 142,875 shares of MRUS stock, worth $6.72 Million. This represents 0.39% of its overall portfolio holdings.
Number of Shares
142,875
Previous 18,701
664.0%
Holding current value
$6.72 Million
Previous $934,000
543.15%
% of portfolio
0.39%
Previous 0.06%
Shares
3 transactions
Others Institutions Holding MRUS
# of Institutions
202Shares Held
60.7MCall Options Held
111KPut Options Held
85.7K-
Rtw Investments, LP New York, NY4.17MShares$196 Million2.86% of portfolio
-
Commodore Capital LP New York, NY3.87MShares$182 Million16.32% of portfolio
-
Wellington Management Group LLP Boston, MA3.5MShares$164 Million0.03% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY2.97MShares$140 Million3.1% of portfolio
-
Samlyn Capital, LLC New York, NY2.67MShares$125 Million1.81% of portfolio
About Merus N.V.
- Ticker MRUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,878,200
- Market Cap $2.16B
- Description
- Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...